ONPH OTC
Oncology Pharma Inc.
1W: -25.0%
1M: -55.8%
3M: -40.2%
YTD: +650.0%
1Y: +5900.0%
3Y: -91.7%
5Y: -99.9%
$0.03
-0.01 (-32.28%)
Weekly Expected Move ±55.2%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$369K
+414.8% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
$369K
+414.8% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$5K
-169.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2004 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | -$850K | -$208K | -$97M | -$105M |
| Depreciation & Amort. | $81K | $1K | $1K | $779 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$381K | $35K | -$196K | $326K | $358K |
| Other Non-Cash Items | -$135K | $777K | $380K | $97M | $105M |
| Operating Cash Flow | -$2M | -$37K | -$22K | -$117K | $369K |
| — Investing Activities — | |||||
| Capital Expenditures | -$17K | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | -$322K | -$2M |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $133K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $116K | $0 | $0 | -$322K | -$2M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $112K | $6K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $546K | $43K | $18K | $0 | $0 |
| Financing Cash Flow | $546K | $43K | $18K | $446K | $1M |
| Net Change in Cash | -$1M | $6K | -$5K | $7K | -$5K |
| Cash End of Period | $8K | $7K | $2K | $9K | $4K |
| Free Cash Flow | -$2M | -$37K | -$22K | -$117K | $369K |